Forbes names ICON in list of Best Employers in America for Women
August 21 2020 - 4:30AM
Business Wire
ICON recognised as top employer for women in
anonymous survey of 75,000 employees
ICON plc, (NASDAQ: ICLR) a leading global provider of
drug development and commercialisation services to the
pharmaceutical, biotechnology and medical device industries today
announced that it has been recognised in the 2020 Forbes List of
America’s Best Employers for Women for the second consecutive
year.
Forbes collaborated with market research firm Statista,
surveying 75,000 Americans, including 45,000 women, working for
businesses that employ more than 1,000 workers. The respondents
spanned 31 industries and were asked to share their opinions on a
series of statements about their respective employers’ culture,
opportunities for career development, image, working conditions,
salary and diversity.
“We’re delighted to be recognised in the Forbes list of Best
Employers for Women for the second consecutive year”, commented Joe
Cronin, Chief Human Resources Officer, ICON. “As the only CRO named
in 2020, we’re proud of our unique culture at ICON and the
resilience of our teams during challenging times. We are committed
to ensuring that all of our employees are able to build fulfilling
and successful careers at ICON and that we create an inclusive
workplace where every employee can bring their best and authentic
selves to work every day in pursuit of our mission to accelerate
the development of medicines that improve and save patient
lives.”
Earlier this year ICON was ranked in Forbes list of 2020 Best
Employers for Diversity. A full list of ICON’s industry awards can
be viewed here.
About ICON plc
ICON plc is a global provider of drug and device development and
commercialisation services to pharmaceutical, biotechnology,
medical device and government and public health organisations. The
company specialises in the strategic development, management and
analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. With
headquarters in Dublin, Ireland, ICON currently operates from 94
locations in 40 countries and has approximately 15,150 employees as
of June 30, 2020.
Further information is available at www.iconplc.com.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
ICON/ICLR-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200821005154/en/
ICON Media Contact Sophie Newington Weber Shandwick +44
(0)7735 580418 snewington@webershandwick.com
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Mar 2024 to Apr 2024
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Apr 2023 to Apr 2024